These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31680136)

  • 1. Clinical Relevance and Prognostic Value of Persistently Negative (1,3)-β-D-Glucan in Adults With Candidemia: A 5-year Experience in a Tertiary Hospital.
    Agnelli C; Bouza E; Del Carmen Martínez-Jiménez M; Navarro R; Valerio M; Machado M; Guinea J; Sánchez-Carrillo C; Alonso R; Muñoz P
    Clin Infect Dis; 2020 Apr; 70(9):1925-1932. PubMed ID: 31680136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains.
    Mikulska M; Ullah N; Magnasco L; Codda G; Bartalucci C; Miletich F; Sepulcri C; Willison E; Vena A; Giacobbe DR; di Pilato V; Robba C; Ball L; Marchese A; Bassetti M
    Clin Microbiol Infect; 2024 Jun; 30(6):822-827. PubMed ID: 38431255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Sensitivity of the (1-3)-β-D-glucan Test for Predicting Candidemia.
    Lee YW; Lim SY; Jin S; Park HJ; Sung H; Kim MN; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Chong YP
    Ann Lab Med; 2023 Jul; 43(4):381-385. PubMed ID: 36843407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed β-(1→3)-D-glucan and mannan antigen kinetics in patients with candidemia.
    Träger J; Dräger S; Mihai S; Cipa F; Busse Grawitz A; Epting T; Meyer R; Rappold E; Held J
    J Clin Microbiol; 2023 Nov; 61(11):e0059823. PubMed ID: 37823667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study.
    Mikulska M; Furfaro E; Magnasco L; Codda G; Giacobbe DR; Dentone C; Vena A; Marchese A; Bassetti M
    Clin Microbiol Infect; 2022 Aug; 28(8):1154.e1-1154.e3. PubMed ID: 35283316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower beta-1,3-D-glucan testing cut-offs increase sensitivity for non-albicans Candida species bloodstream infections.
    Forster J; Dichtl K; Wagener J
    Mycoses; 2022 May; 65(5):500-507. PubMed ID: 35020235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
    Alam FF; Mustafa AS; Khan ZU
    BMC Infect Dis; 2007 Sep; 7():103. PubMed ID: 17784947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia.
    Friedrich R; Rappold E; Bogdan C; Held J
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29899003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia.
    Abe M; Kimura M; Araoka H; Taniguchi S; Yoneyama A
    Med Mycol; 2014 Nov; 52(8):835-40. PubMed ID: 25349254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of β-D-glucan alone or combined with Candida score, colonization index and C-reactive protein for candidemia.
    Kazancioglu S; Bastug A; Kayaaslan B; Mutlu NM; Calci E; Turhan T; Mumcuoglu I; Akinci E; Bodur H
    J Infect Dev Ctries; 2022 Feb; 16(2):362-368. PubMed ID: 35298433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (1,3)-β-D-glucan is able to predict therapeutic failure of patients with candidemia and not only mortality.
    Esteves P; Lopes Lima S; Salles de Azevedo Melo A; Maria Beirão E; Nucci M; Colombo AL
    Mycoses; 2021 Mar; 64(3):264-271. PubMed ID: 33274533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of incorporation of beta-D-glucan and T2Candida testing for diagnosis and treatment of candidemia.
    Zacharioudakis IM; Zervou FN; Marsh K; Siegfried J; Yang J; Decano A; Dubrovskaya Y; Mazo D; Aguero-Rosenfeld M
    Diagn Microbiol Infect Dis; 2024 Feb; 108(2):116107. PubMed ID: 38071859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
    Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
    J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.
    Prüller F; Wagner J; Raggam RB; Hoenigl M; Kessler HH; Truschnig-Wilders M; Krause R
    Med Mycol; 2014 Jul; 52(5):455-61. PubMed ID: 24906361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diagnostic Relevance of β-D-Glucan for Candidemia within Internal Medicine Wards.
    Corcione S; Chasseur L; Lupia T; Shbaklo N; Scabini S; Filippini C; Mornese Pinna S; Morra di Celle S; Cavallo R; De Rosa FG
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil.
    Giacobbe DR; Esteves P; Bruzzi P; Mikulska M; Furfaro E; Mesini A; Tatarelli P; Grignolo S; Viscoli C; Colombo AL; Del Bono V
    Clin Microbiol Infect; 2015 Oct; 21(10):954.e9-17. PubMed ID: 26070961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative sensitivity of 1,3 beta-D-glucan for common causes of candidaemia in South Africa.
    Chibabhai V; Fadana V; Bosman N; Nana T
    Mycoses; 2019 Nov; 62(11):1023-1028. PubMed ID: 31393662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.
    Held J; Kohlberger I; Rappold E; Busse Grawitz A; Häcker G
    J Clin Microbiol; 2013 Apr; 51(4):1158-64. PubMed ID: 23363830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unit.
    Gill CM; Kenney RM; Hencken L; Mlynarek ME; Alangaden GJ; Samuel LP; Davis SL
    Diagn Microbiol Infect Dis; 2019 Oct; 95(2):162-165. PubMed ID: 31248660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Performance of the Dynamiker Fungus (1-3)-β-D-Glucan and Fungitell Assay for Diagnosis of Candidemia: Need for New Cut-off Development and Test Validation.
    Yazdanpanah S; Rahbarmah M; Motamedi M; Khodadadi H
    Diagn Microbiol Infect Dis; 2024 Feb; 108(2):116118. PubMed ID: 37992564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.